Literature DB >> 21125163

Prevalence of IgA deficiency in adult systemic lupus erythematosus and the study of the association with its clinical and autoantibody profiles.

Ana Paula França Mantovani1, Mariel Perini Monclaro, Thelma L Skare.   

Abstract

INTRODUCTION: IgA deficiency (IgAD) is the most common primary immunodeficiency, which can cause frequent infections. The association of IgA deficiency with systemic lupus erythematosus (SLE) is very important because of the high morbidity and mortality rates of infections in patients with this disease.
OBJECTIVES: To study the prevalence of IgA deficiency in SLE patients from southern Brazil and to compare the clinical and autoantibody profiles of SLE patients with and without IgA deficiency. PATIENTS AND METHODS: One hundred and eighty-nine SLE patients were submitted to serum IgA measurement by nephelometry. Levels of IgA below 50mg/dL were considered to be IgAD. Demographic data, clinical profile (presence of arthritis, psychosis, seizures, stroke, serositis, hemolytic anemia, leucopenia, thrombocytopenia, and nephritis) and autoantibody profiles (ANA, anti-Ro, anti-La, anti-Sm, anti-DNA, anti-RNP, lupus anticoagulant, and anticardiolipin IgG and IgM) were obtained from reviewing medical records. As control, we used literature data from another study performed in the same geographical area. Data were analyzed through contingency and frequency tables, applying the Chi-square, Fisher, and Mann Whitney tests.
RESULTS: IgA deficiency was found in 11 (6.17%) patients (P < 0.001 in relation to controls). The association between IgA deficiency and clinical or autoantibody profile was not significant.
CONCLUSION: We concluded that a higher prevalence of IgA deficiency was observed in lupus patients than in controls. Deficiency of IgA did not have any particular laboratory or clinical effects on this population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21125163

Source DB:  PubMed          Journal:  Rev Bras Reumatol        ISSN: 0482-5004


  8 in total

Review 1.  Selective IgA deficiency in autoimmune diseases.

Authors:  Ning Wang; Nan Shen; Timothy J Vyse; Vidya Anand; Iva Gunnarson; Gunnar Sturfelt; Solbritt Rantapää-Dahlqvist; Kerstin Elvin; Lennart Truedsson; Bengt A Andersson; Charlotte Dahle; Eva Ortqvist; Peter K Gregersen; Timothy W Behrens; Lennart Hammarström
Journal:  Mol Med       Date:  2011-08-04       Impact factor: 6.354

2.  Hydroxychloroquine Therapy and Serum Immunoglobulin Levels in Women with IgG Subclass Deficiency and Systemic Lupus Erythematosus, Sjögren Syndrome, and Rheumatoid Arthritis: A Retrospective Study.

Authors:  James C Barton; J Clayborn Barton; Luigi F Bertoli
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-04-11       Impact factor: 4.291

3.  Association between IgA deficiency & other autoimmune conditions: a population-based matched cohort study.

Authors:  Jonas F Ludvigsson; Martin Neovius; Lennart Hammarström
Journal:  J Clin Immunol       Date:  2014-03-02       Impact factor: 8.317

Review 4.  Epstein-Barr virus and systemic lupus erythematosus.

Authors:  Anette Holck Draborg; Karen Duus; Gunnar Houen
Journal:  Clin Dev Immunol       Date:  2012-07-03

5.  Anaphylactic transfusion reaction in a patient with anhaptoglobinemia: the first case in Korea.

Authors:  Hyunsoo Kim; Jonghyeon Choi; Kyoung Un Park; Hyon-Suk Kim; Yoo Hong Min; Moon Jung Kim; Hyun Ok Kim
Journal:  Ann Lab Med       Date:  2012-06-20       Impact factor: 3.464

Review 6.  Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice.

Authors:  Beatriz Tavares Costa-Carvalho; Anete Sevciovic Grumach; José Luis Franco; Francisco Javier Espinosa-Rosales; Lily E Leiva; Alejandra King; Oscar Porras; Liliana Bezrodnik; Mathias Oleastro; Ricardo U Sorensen; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2013-11-16       Impact factor: 8.317

7.  Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis.

Authors:  Barbara Dema; Christophe Pellefigues; Sarfaraz Hasni; Nathalie Gault; Chao Jiang; Tiffany K Ricks; Michael M Bonelli; Jörg Scheffel; Karim Sacré; Mathieu Jablonski; Delphine Gobert; Thomas Papo; Eric Daugas; Gabor Illei; Nicolas Charles; Juan Rivera
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

8.  Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins.

Authors:  Venkat Reddy; Lina Martinez; David A Isenberg; Maria J Leandro; Geraldine Cambridge
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-04-24       Impact factor: 4.794

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.